Related references
Note: Only part of the references are listed.Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia
Alexander C. Leeksma et al.
LEUKEMIA (2019)
Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC)
Fady M. Mikhail et al.
GENETICS IN MEDICINE (2019)
Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
Panagiotis Baliakas et al.
BLOOD (2019)
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Rishu Agarwal et al.
NATURE MEDICINE (2019)
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
Michael Hallek et al.
BLOOD (2018)
In chronic lymphocytic leukaemia with complex karyotype, major structural abnormalities identify a subset of patients with inferior outcome and distinct biological characteristics
Gian Matteo Rigolin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
Paul M. Barr et al.
HAEMATOLOGICA (2018)
ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation
J. Malcikova et al.
LEUKEMIA (2018)
Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: extended phase 3 results from RESONATE-2
Paul M. Barr et al.
HAEMATOLOGICA (2018)
Assessing copy number aberrations and copy neutral loss of heterozygosity across the genome as best practice: An evidence based review of clinical utility from the cancer genomics consortium (CGC) working group for myelodysplastic syndrome, myelodysplastic/myeloproliferative and myeloproliferative neoplasms
Rashmi Kanagal-Shamanna et al.
CANCER GENETICS (2018)
Assessing genome-wide copy number aberrations and copy-neutral loss-of-heterozygosity as best practice: An evidence-based review from the Cancer Genomics Consortium working group for plasma cell disorders
Trevor J. Pugh et al.
CANCER GENETICS (2018)
Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia
Kathy Chun et al.
CANCER GENETICS (2018)
Assessing copy number abnormalities and copy-neutral loss-of-heterozygosity across the genome as best practice in diagnostic evaluation of acute myeloid leukemia: An evidence-based review from the cancer genomics consortium (CGC) myeloid neoplasms working group
Xinjie Xu et al.
CANCER GENETICS (2018)
Survival of Del17p CLL Depends on Genomic Complexity and Somatic Mutation
Lijian Yu et al.
CLINICAL CANCER RESEARCH (2017)
Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia
Yannick Le Bris et al.
HEMATOLOGICAL ONCOLOGY (2017)
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: updated ERIC recommendations
R. Rosenquist et al.
LEUKEMIA (2017)
SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia
Brenton G. Mar et al.
BLOOD (2017)
Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax
Mary Ann Anderson et al.
BLOOD (2017)
Complex karyotypes and KRAS and POT1 mutations impact outcome in CLL after chlorambucil-based chemotherapy or chemoimmunotherapy
Carmen Diana Herling et al.
BLOOD (2016)
Guidelines for genomic array analysis in acquired haematological neoplastic disorders
Jacqueline Schoumans et al.
GENES CHROMOSOMES & CANCER (2016)
Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia
H. Parker et al.
LEUKEMIA (2016)
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A. Burger et al.
NATURE COMMUNICATIONS (2016)
Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations
Gonzalo Blanco et al.
ONCOTARGET (2016)
Complex Karyotype is a Stronger Predictor Than Del(17p) for an Inferior Outcome in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib-Based Regimens
Philip A. Thompson et al.
CANCER (2015)
Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: A systematic reappraisal of classic cytogenetic data
Panagiotis Baliakas et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage
Ruth Clifford et al.
BLOOD (2014)
Identification of prognostic relevant chromosomal abnormalities in chronic lymphocytic leukemia using microarray-based genomic profiling
Marian J. P. L. Stevens-Kroef et al.
MOLECULAR CYTOGENETICS (2014)
Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescence in situ hybridization techniques?
Anna Puiggros et al.
LEUKEMIA & LYMPHOMA (2013)
High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations
Jennifer Edelmann et al.
BLOOD (2012)
Genome-Wide Arrays in Routine Diagnostics of Hematological Malignancies
Annet Simons et al.
HUMAN MUTATION (2012)
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
S. J. L. Knight et al.
LEUKEMIA (2012)
Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia
Peter Ouillette et al.
BLOOD (2011)
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
Rebeqa Gunnarsson et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Comparison of array comparative genomic hybridization (aCGH) to FISH and cytogenetics in prognostic evaluation of chronic lymphocytic leukemia
D. P. O'Malley et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2011)
13q deletion anatomy and disease progression in patients with chronic lymphocytic leukemia
H. Parker et al.
LEUKEMIA (2011)
Evaluation of chronic lymphocytic leukemia by oligonucleotide-based microarray analysis uncovers novel aberrations not detected by FISH or cytogenetic analysis
Kathryn A. Kolquist et al.
MOLECULAR CYTOGENETICS (2011)
Array-Based Karyotyping for Prognostic Assessment in Chronic Lymphocytic Leukemia Performance Comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 Arrays
Jill M. Hagenkord et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Customized Oligonucleotide Array-Based Comparative Genomic Hybridization as a Clinical Assay for Genomic Profiling of Chronic Lymphocytic Leukemia
Rachel Sargent et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2009)
Molecular allelokaryotyping of early-stage, untreated chronic lymphocytic leukemia
Soeren Lehmann et al.
CANCER (2008)
Whole-genome scanning by array comparative genomic hybridization as a clinical tool for risk assessment in chronic lymphocytic leukemia
Shelly R. Gunn et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2008)
Comprehensive genetic characterization of CLL:: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgVH status and immunophenotyping
C. Haferlach et al.
LEUKEMIA (2007)
High-resolution oligonucleotide array-CGH pinpoints genes involved in cryptic losses in chronic lymphocytic leukemia
A. Tyybakinoja et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia
A Kröber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
